AstraZeneca's Imfinzi Improves Survival in Late-stage Lung Cancer Trial AstraZeneca's Imfinzi Improves Survival in Late-stage Lung Cancer Trial
AstraZeneca said on Friday its blockbuster cancer drug Imfinzi helped improve survival in patients in the early stages of an aggressive type of lung cancer, making it the...Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 5, 2024 Category: Allergy & Immunology Tags: Hematology-Oncology Source Type: news
S2 Episode 4: RSV Prevention and Transmission in Healthcare Facilities S2 Episode 4: RSV Prevention and Transmission in Healthcare Facilities
Join Drs Forest Arnold and Hannah Nam as they discuss preventing RSV outbreaks within healthcare facilities, and strategies to minimize RSV transmission among healthcare workers and patients.Medscape (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 3, 2024 Category: Allergy & Immunology Tags: Infectious Diseases InDiscussion Source Type: news
Twice-Daily PPI Leads to Higher EoE Remission Rates Twice-Daily PPI Leads to Higher EoE Remission Rates
The most optimal proton pump inhibitor regimen for histologic response in EoE may be a twice-daily moderate dose, with no additional benefits of a higher dose.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 2, 2024 Category: Allergy & Immunology Tags: Gastroenterology Source Type: news
Tuberculosis Screening Gaps Persist in New DMARD Users Tuberculosis Screening Gaps Persist in New DMARD Users
Substantial patient safety gaps regarding latent tuberculosis screening persist among new users of biologic or targeted synthetic DMARDs, suggested a nationwide cohort study.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 2, 2024 Category: Allergy & Immunology Tags: Rheumatology Source Type: news
Multiple Sclerosis and Epstein-Barr Virus: What Do We Know? Multiple Sclerosis and Epstein-Barr Virus: What Do We Know?
Research suggested that EBV is the primary cause of MS. What are the clinical implications, and could this transform treatment and prevention of this neurodegenerative condition?Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 2, 2024 Category: Allergy & Immunology Tags: Neurology & Neurosurgery Source Type: news
A Banned Chemical That Is Still Causing Cancer A Banned Chemical That Is Still Causing Cancer
This is one time when being at the top of the food chain is not advantageous.Medscape (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 1, 2024 Category: Allergy & Immunology Tags: Internal Medicine Commentary Source Type: news
First-of-Its-Kind RA Research Summit Offers Diverse Program First-of-Its-Kind RA Research Summit Offers Diverse Program
The Arthritis Foundation has partnered with the Hospital for Special Surgery to host a 2-day meeting on RA, assembling researchers who pursue a diverse array of strategies to potentially improve care.Hospital for Special Surgery (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 1, 2024 Category: Allergy & Immunology Tags: Rheumatology Source Type: news
Full-Dose Beta-Lactam Allergy Challenges in ED Full-Dose Beta-Lactam Allergy Challenges in ED
Full-dose challenges were safely conducted for ED patients with moderate, severe, or unknown beta-lactam allergies, thereby avoiding unnecessary penicillin skin testing and reducing suboptimal antibiotic use.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - April 1, 2024 Category: Allergy & Immunology Tags: Emergency Medicine Source Type: news
Episode 2: COPD: The Right Inhaled Medication at the Right Price Episode 2: COPD: The Right Inhaled Medication at the Right Price
Join Drs Leah Witt and Amber Martirosov as they discuss inhaled medications for chronic obstructive pulmonary disease, overlooked nuances of inhaler technique and why understanding Medicare is a critical part of providing care.Medscape (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 26, 2024 Category: Allergy & Immunology Tags: Pulmonary Medicine InDiscussion Source Type: news
Europe's Quest for Earlier Diagnosis of Psoriatic Arthritis Europe's Quest for Earlier Diagnosis of Psoriatic Arthritis
The HIPPOCRATES consortium aims to help predict those who will develop the condition, diagnose it earlier, and one day even prevent it.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 25, 2024 Category: Allergy & Immunology Tags: Rheumatology Source Type: news
Immunomodulators Do Not Affect COVID-19 Vaccine Efficacy Immunomodulators Do Not Affect COVID-19 Vaccine Efficacy
A study suggested that immunomodulatory medications do not increase the risk for COVID-19 related hospitalizations in patients who have received the COVID-19 vaccine.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 21, 2024 Category: Allergy & Immunology Tags: Dermatology Source Type: news
Getting Reluctant Patients to'Yes' on COVID Vaccination Getting Reluctant Patients to'Yes' on COVID Vaccination
Five useful tips for helping the vax-hesitant people get past their objections.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 20, 2024 Category: Allergy & Immunology Tags: Infectious Diseases Source Type: news
Patients With Sj ögren Syndrome Fall Into Distinct Subgroups Patients With Sj ögren Syndrome Fall Into Distinct Subgroups
Those with high systemic disease activity but low symptom burden fared worse over time.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 20, 2024 Category: Allergy & Immunology Tags: Rheumatology Source Type: news
Roflumilast Cream Quickly Improved AD in Children, Ages 2-5 Roflumilast Cream Quickly Improved AD in Children, Ages 2-5
Among patients treated with roflumilast cream, 0.05%, 25.4% reached the primary endpoint of " clear " or " almost clear " plus a two-grade improvement from baseline at week 4.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 19, 2024 Category: Allergy & Immunology Tags: Dermatology Source Type: news
AstraZeneca to Cap Out-of-pocket Inhaler Costs in US, Following Rival Boehringer's Move AstraZeneca to Cap Out-of-pocket Inhaler Costs in US, Following Rival Boehringer's Move
Drugmaker AstraZeneca said on Monday it would cap out-of-pocket costs for its inhaled respiratory products at $35 per month in the United States from June, following a...Reuters Health Information (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - March 19, 2024 Category: Allergy & Immunology Tags: Pulmonary Medicine Source Type: news
